GGrantIndex
← Leaderboards

Naji N Abumrad

Sinai Hospital Of Baltimore

$9,672,284
Attributed
$13,170,859
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200519
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$13,170,859 · 13

By mechanism

R01$11,794,471 · 6
R24$1,212,333 · 1
M01$164,055 · 6

Others in their field

Top investigators on “Metabolic

Research focus

MetabolicObesityInsulin SensitivityBariatric SurgeryProductionTissuesBaseMediatingGastric BypassBody Weight DecreasedOperative Surgical ProceduresInflammatoryInsulinDietSignal TransductionHepaticLeadFatty Acid Glycerol EstersResponseLiverCytokineMorbid ObesityComorbidityGlucose

Grant awards (36)

ROLE OF CD36 IN NUTRIENT DELIVERY AND ITS DYSFUNCTION IN AFRICAN AMERICANS$414,416
R01 · FY2019 · DK
Bile Diversion: A Simple and Effective Method of Treating Obesity$355,500
R01 · FY2019 · DK
ROLE OF CD36 IN NUTRIENT DELIVERY AND ITS DYSFUNCTION IN AFRICAN AMERICANS$496,604
R01 · FY2018 · DK
Bile Diversion: A Simple and Effective Method of Treating Obesity$355,500
R01 · FY2018 · DK
ROLE OF CD36 IN NUTRIENT DELIVERY AND ITS DYSFUNCTION IN AFRICAN AMERICANS$485,027
R01 · FY2017 · DK
Bile Diversion: A Simple and Effective Method of Treating Obesity$355,500
R01 · FY2017 · DK · contact PI
Role of the foregut in nutrient metabolism in lean and obese humans$343,650
R01 · FY2017 · DK · contact PI
ROLE OF CD36 IN NUTRIENT DELIVERY AND ITS DYSFUNCTION IN AFRICAN AMERICANS$519,185
R01 · FY2016 · DK
Bile Diversion: A Simple and Effective Method of Treating Obesity$209,320
R01 · FY2016 · DK · contact PI
Bile Diversion: A Simple and Effective Method of Treating Obesity$144,847
R01 · FY2016 · DK · contact PI
Bile Diversion: A Simple and Effective Method of Treating Obesity$353,250
R01 · FY2015 · DK · contact PI
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$335,823
R01 · FY2015 · DK · contact PI
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$255,220
R01 · FY2015 · DK · contact PI
Molecular and Cellular Basis for the Efficacy of Bariatric Surgery$600,303
R24 · FY2014 · DK
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$591,237
R01 · FY2014 · DK · contact PI
Molecular and Cellular Basis for the Efficacy of Bariatric Surgery$612,030
R24 · FY2013 · DK
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$570,736
R01 · FY2013 · DK · contact PI
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$591,640
R01 · FY2012 · DK · contact PI
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis$622,146
R01 · FY2011 · DK · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$991,557
R01 · FY2009 · DK · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$657,706
R01 · FY2008 · DK · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$387,147
R01 · FY2008 · DK · contact PI
OMENTUM AND TREATMENT OF MORBID OBESITY$2,893
M01 · FY2008 · RR · contact PI
GUT MICROBIOTA AND HUMAN ENERGY EXPENDITURE$562
M01 · FY2008 · RR · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$660,196
R01 · FY2007 · DK · contact PI
OMENTUM AND TREATMENT OF MORBID OBESITY$61,413
M01 · FY2007 · RR · contact PI
GUT MICROBIOTA AND HUMAN ENERGY EXPENDITURE$11,936
M01 · FY2007 · RR · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$673,398
R01 · FY2006 · DK · contact PI
OMENTUM AND TREATMENT OF MORBID OBESITY$79,700
M01 · FY2006 · RR · contact PI
GUT MICROBIOTA AND HUMAN ENERGY EXPENDITURE$7,551
M01 · FY2006 · RR · contact PI
Role of the Omentum in the Treatment of Morbid Obesity$674,360
R01 · FY2005 · DK
Role of the Omentum in the Treatment of Morbid Obesity$113,813
R01 · FY2005 · DK
PROTEOLYSIS IN HYPOGLYCEMIA, IMPACT OF CNS$143,981
R01 · FY2002 · DK
PROTEOLYSIS IN HYPOGLYCEMIA, IMPACT OF CNS$225,802
R01 · FY2001 · DK
PROTEOLYSIS IN HYPOGLYCEMIA, IMPACT OF CNS$208,084
R01 · FY2000 · DK
PROTEOLYSIS IN HYPOGLYCEMIA, IMPACT OF CNS$58,826
R01 · FY2000 · DK